SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" meme coin is gaining traction, with the community rallying behind its unique branding and "caw caw" battle cry. Active discussion revolves around its potential as a multichain gem and its strong, engaged community. Some users highlight the token's burn mechanisms.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending amidst discussions around its achieved quantum performance milestone and potential implications for the sector. The community is debating its valuation, future growth prospects, and competition within the quantum computing landscape, with some highlighting potential government contracts and partnerships while others express skepticism about commercial viability and dilution concerns.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending amidst discussions about its valuation, partnership with Nvidia, and significant deals with major industry players like OpenAI and Microsoft. Community members are debating the sustainability of GPU pricing and the potential impact of debt, while others focus on the company's growth prospects within the AI infrastructure sector. Bullish investors highlight long-term potential and reiterate the stock's connection to the AI revolution.

abrdn ETF - abrdn Physical Platinum Shares ETF

PPLT is trending as traders assess whether it's undervalued relative to gold and silver, with some anticipating a breakout from a multi-year consolidation. Discussions include the potential for increased platinum demand due to industrial applications and potential supply deficits. Some traders are considering trimming their positions, while others are buying, anticipating a move towards higher price targets.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending after announcing positive Phase 2 trial data for its skin drug, leading to speculation about a potential buyout and future gains, though some express concern about an upcoming share offering. The community is actively discussing the drug's efficacy, comparing it to competitors, and debating its potential market value. Some traders are trying to navigate overnight trading restrictions and the possibility of shorting the stock.

ETF Series Solutions Trust - Defiance Quantum ETF

QTUM is trending due to growing interest in quantum computing, with community members actively discussing the ETF's potential upside and its exposure to key players like IONQ and RGTI. Bullish sentiment is fueled by significant options activity and the expectation that government and commercial applications of quantum computing will expand. Some investors see it as a way to diversify into the quantum sector instead of choosing individual names.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as the community discusses potential partnerships with Apple and TSMC, which could significantly boost its foundry business. Bullish sentiment is fueled by government support and investment from Nvidia, although some traders are wary of the stock being overbought after a recent surge. Discussions also include potential implications of geopolitical tensions, particularly concerning Taiwan, and how that may affect Intel's position in the chip manufacturing landscape.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as community members discuss the potential impact of its oral Wegovy pill, which showed promising weight loss results in trials, and its recent EU approval for diabetes treatment. Some traders express frustration with NVO's price action despite positive news, while others see long-term value due to the company's strong pipeline and market position in obesity and diabetes care. Discussions also include potential competition from other pharmaceutical companies and the impact of new tariffs.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending amid discussions surrounding its financial health, technical analysis indicating a potential uptrend, and unusual options activity. The community is actively discussing potential breakout levels and call option opportunities, as well as the company's legal challenges related to talc and Tylenol. Some are optimistic due to Trump's proposed tariffs potentially benefiting domestic pharma manufacturers like JNJ.

Tidal Trust II - Defiance Daily Target 2X Long HIMS ETF

Defiance Daily Target 2X Long HIMS ETF

Recent community chatter around HIMZ is focused on its potential for significant gains, with some traders pointing to unusual options activity and a possible FDA compliance catalyst. There's a mix of bullish sentiment and caution, as some traders are wary of potential risks and volatility, while others are highlighting the potential for a substantial upward move based on technical analysis. HIMZ, being a 2x leveraged ETF of HIMS, amplifies the underlying stock's movements, leading to discussions about both potential rewards and risks associated with its daily rebalancing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Current Price	$17.15
Prev Close	$16.50
Open	$16.98
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

LPSB
Laporte Bancorp, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest LPSB News

LPSB Laporte Bancorp, Inc.